On 2/26/24, Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 21.1%, closing at $8.31. Moreover, trading volume in this advance was exceptionally high at 324% of normal. Relative to the market the stock has been weak over the last nine months but has risen 41.3% during the last week.
Current PriceTarget Research Rating
ATNM’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Actinium Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Actinium Pharmaceuticals has a very low Power Rating of 11 and a very low Appreciation Score of 4, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment